Aligos Therapeutics Inc. (ALGS): Price and Financial Metrics
ALGS Price/Volume Stats
| Current price | $11.44 | 52-week high | $46.80 |
| Prev. close | $10.28 | 52-week low | $6.76 |
| Day low | $10.62 | Volume | 137,700 |
| Day high | $11.76 | Avg. volume | 269,992 |
| 50-day MA | $24.78 | Dividend yield | N/A |
| 200-day MA | $17.62 | Market Cap | 69.94M |
ALGS Stock Price Chart Interactive Chart >
Aligos Therapeutics Inc. (ALGS) Company Bio
Aligos Therapeutics, Inc. develops targeted, curative therapies for hepatologic diseases and viral infections. It engages in building a pipeline of drug candidates which targets multiple clinically validated mechanisms of action and are designed to achieve functional cure for CHB and become transformative treatment options for COVID-19 and NASH. The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA.
ALGS Price Returns
| 1-mo | -45.55% |
| 3-mo | -66.42% |
| 6-mo | -19.55% |
| 1-year | -50.34% |
| 3-year | -82.26% |
| 5-year | N/A |
| YTD | -71.29% |
| 2024 | 140.00% |
| 2023 | -30.32% |
| 2022 | -91.97% |
| 2021 | -57.07% |
| 2020 | N/A |
Loading social stream, please wait...